Psychotropics and COVID-19: An analysis of safety and prophylaxis - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue L'Encéphale Année : 2021

Psychotropics and COVID-19: An analysis of safety and prophylaxis

Résumé

The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes should be made to pharmacological treatments prescribed to mental health patients? Secondly, are there any positive side effects of these substances against SARS-CoV-2? Our aim was to analyze usage safety of psychotropics during COVID-19; therefore, herein, we have studied: (i) the risk of symptomatic complications of COVID-19 associated with the use of these drugs, notably central nervous system activity depression, QTc interval enlargement and infectious and thromboembolic complications; (ii) the risk of mistaking the iatrogenic impact of psychotropics with COVID-19 symptoms, causing diagnostic error. Moreover, we provided a summary of the different information available today for these risks, categorized by mental health disorder, for the following: schizophrenia, bipolar disorder, anxiety disorder, ADHD, sleep disorders and suicidal risk. The matter of psychoactive substance use during the pandemic is also analyzed in this paper, and guideline websites and publications for psychotropic treatments in the context of COVID-19 are referenced during the text, so that changes on those guidelines and eventual interaction between psychotropics and COVID-19 treatment medication can be reported and studied. Finally, we also provide a literature review of the latest known antiviral properties of psychotropics against SARS-CoV-2 as complementary information.
Fichier principal
Vignette du fichier
Javelot et al-2021-Psychotropics and COVID-19.pdf (1001.94 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03369863 , version 1 (15-10-2021)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Hervé Javelot, Céline Straczek, Guillaume Meyer, Clara Gitahy Falcao Faria, Luisa Weiner, et al.. Psychotropics and COVID-19: An analysis of safety and prophylaxis. L'Encéphale, 2021, 47 (6), pp.564-588. ⟨10.1016/j.encep.2021.08.002⟩. ⟨hal-03369863⟩
69 Consultations
52 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More